Part Details | USP FUROSEMIDE TABLETS
6505-00-062-3336
Alternate Parts: NDC00378021601, NDC00378-0216-01, NDC00378021601, NDC00378-0216-01, NDC00054429925, NDC00054-4299-25, NDC00781196601, NDC00781-1966-01, NDC00364051401, NDC00364-0514-01, NDC30698006001, NDC30698-0060-01, 6505-00-062-3336, 00-062-3336, 6505000623336, 000623336
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | JUN 20, 1967 | 00-062-3336 | 30946 ( FUROSEMIDE TABLETS, USP ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-00-062-3336
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC00378-0216-01 | 60895 | MYLAN PHARMACEUTICALS INC |
| NDC00378-0216-01 | 3KJG9 | MYLAN PHARMACEUTICALS INC. |
| NDC00054-4299-25 | 1H5R4 | ROXANE LABORATORIES, INC.DIV SUB OF BOEHRINGER INGELHEIM |
| NDC00781-1966-01 | 0THL4 | SANDOZ INC. |
| NDC00364-0514-01 | 0PTT8 | SCHEIN PHARMACEUTICAL INC |
| NDC30698-0060-01 | 4W8M6 | VALIDUS PHARMACEUTICALS LLC |
Technical Data | NSN 6505-00-062-3336
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB40.000 MILLIGRAMS FUROSEMIDE |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| SPECIAL FEATURES | W/CHILD-PROOF SAFETY CLOSURE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | FUROSEMIDE TABLETS USP 40 MG 100 TABLETS PER BOTTLE |